blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3384925

EP3384925 - COMPOSITION FOR TREATING HYPERLIPIDEMIA COMPRISING OXYNTOMODULIN DERIVATIVE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.07.2021
Database last updated on 21.08.2024
FormerThe patent has been granted
Status updated on  31.07.2020
FormerGrant of patent is intended
Status updated on  05.03.2020
FormerRequest for examination was made
Status updated on  05.04.2019
FormerThe application has been published
Status updated on  07.09.2018
Most recent event   Tooltip03.05.2024Lapse of the patent in a contracting state
New state(s): MK		published on 05.06.2024  [2024/23]
Applicant(s)For all designated states
Hanmi Pharm. Co., Ltd.
214 Muha-ro
Paltan-myeon
Hwaseong-si, Gyeonggi-do 445-958 / KR
[2018/41]
Inventor(s)01 / Jung, Sung Youb
109-105 World Meridian
Uman-dong
Paldal-gu
Suwon-si
442-190 Gyeonggi-do / KR
02 / Kim, Jin-Sun
103-1501 Minsokmaeul Ssangyong Apt.
553 Bora-dong
Giheung-gu
Yongin-si
446-954 Gyeonggi-do / KR
03 / Jang, Myung Hyun
137-2403 Gangdong Lotte Castle First Apt.
Amsa 3-dong
Gangdong-gu
134-716 Seoul / KR
04 / Lee, Sang Hyun
107-306 Hyundai Apt.
Oksu-dong
Seongdong-gu
133-100 Seoul / KR
05 / Choi, In Young
105-1801 Byeoksan 1-cha Apt.
Jukjeon 2-dong
Suji-gu
Yongin-si
448-755 Gyeonggi-do / KR
06 / Kwon, Se Chang
408-1804 Dogok Rexle Apt.
Dogok 2-dong
Gangnam-gu
135-506 Seoul / KR
 [2018/41]
Representative(s)Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Ganghoferstraße 68 B
80339 München / DE
[2018/41]
Application number, filing date18169490.225.07.2013
[2018/41]
Priority number, dateKR2012008147525.07.2012         Original published format: KR 20120081475
[2018/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3384925
Date:10.10.2018
Language:EN
[2018/41]
Type: B1 Patent specification 
No.:EP3384925
Date:02.09.2020
Language:EN
[2020/36]
Search report(s)(Supplementary) European search report - dispatched on:EP17.08.2018
ClassificationIPC:A61K47/68, A61K47/64, A61K47/60, A61K47/59, A61K38/22, A61P3/06, A61P1/16, A61P9/10
[2020/14]
CPC:
A61K38/26 (EP,CN,IL,KR,RU,US); A61K45/06 (CN,IL,US); A61K38/16 (IL,KR);
A61K38/22 (CN,IL,US); A61K47/59 (EP,IL,US); A61K47/593 (EP,IL,US);
A61K47/60 (EP,IL,US); A61K47/643 (EP,IL,US); A61K47/6435 (EP,IL,US);
A61K47/68 (EP,IL,RU,US); A61K47/6811 (EP,IL,US); A61P1/16 (EP,IL);
A61P3/00 (EP,IL); A61P3/04 (EP,IL); A61P3/06 (EP,IL,RU);
A61P3/10 (EP,IL); A61P31/14 (EP,IL); A61P31/20 (EP,IL);
A61P43/00 (EP,IL); A61P9/10 (EP,IL); C07K14/605 (IL,RU,US);
C07K14/76 (IL,US); C07K14/78 (IL,US); C07K19/00 (IL,RU) (-)
C-Set:
A61K38/22, A61K2300/00 (CN);
A61K38/26, A61K2300/00 (CN)
Former IPC [2020/13]A61K38/22, A61K47/59, A61K47/60, A61K47/64, A61K47/68, A61P3/06, A61P1/16, A61P9/10
Former IPC [2018/41]A61K38/22, A61K47/59, A61P3/00, A61P9/10, A61K47/68, A61K47/60, A61P1/16, A61P3/06, A61K47/64
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/19]
Former [2018/41]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:ZUSAMMENSETZUNG ZUR BEHANDLUNG VON HYPERLIPIDÄMIE MIT EINEM OXYNTOMODULINDERIVAT[2018/41]
English:COMPOSITION FOR TREATING HYPERLIPIDEMIA COMPRISING OXYNTOMODULIN DERIVATIVE[2018/41]
French:COMPOSITION POUR TRAITER L'HYPERLIPIDÉMIE COMPRENANT UN DÉRIVÉ D'OXYNTOMODULINE[2018/41]
Examination procedure27.03.2019Amendment by applicant (claims and/or description)
27.03.2019Examination requested  [2019/19]
27.03.2019Date on which the examining division has become responsible
06.03.2020Communication of intention to grant the patent
16.07.2020Fee for grant paid
16.07.2020Fee for publishing/printing paid
16.07.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP13823727.6  / EP2884994
Divisional application(s)EP20188520.9  / EP3766520
Opposition(s)03.06.2021No opposition filed within time limit [2021/32]
Fees paidRenewal fee
21.05.2018Renewal fee patent year 03
21.05.2018Renewal fee patent year 04
21.05.2018Renewal fee patent year 05
11.07.2018Renewal fee patent year 06
15.07.2019Renewal fee patent year 07
23.07.2020Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU25.07.2013
AL02.09.2020
CY02.09.2020
CZ02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
MK02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
[2024/23]
Former [2023/33]HU25.07.2013
AL02.09.2020
CY02.09.2020
CZ02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
Former [2023/30]AL02.09.2020
CY02.09.2020
CZ02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
Former [2022/18]AL02.09.2020
CZ02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
MC02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
Former [2021/36]AL02.09.2020
CZ02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SI02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
Former [2021/28]AL02.09.2020
CZ02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SK02.09.2020
SM02.09.2020
BG02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
Former [2021/25]AL02.09.2020
CZ02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SM02.09.2020
BG02.12.2020
GR03.12.2020
IS02.01.2021
PT04.01.2021
Former [2021/22]CZ02.09.2020
EE02.09.2020
FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
PL02.09.2020
RO02.09.2020
RS02.09.2020
SM02.09.2020
BG02.12.2020
GR03.12.2020
PT04.01.2021
Former [2021/21]FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
PL02.09.2020
RS02.09.2020
BG02.12.2020
GR03.12.2020
PT04.01.2021
Former [2021/10]FI02.09.2020
HR02.09.2020
LT02.09.2020
LV02.09.2020
PL02.09.2020
RS02.09.2020
BG02.12.2020
GR03.12.2020
Former [2021/08]FI02.09.2020
LT02.09.2020
BG02.12.2020
Former [2021/07]FI02.09.2020
LT02.09.2020
Documents cited:Search[AP]WO2012169798  (HANMI SCIENCE CO LTD [KR], et al) [AP] 1-14 * page 1, paragraphs 1, 4 * * page 11, paragraph 153 ** page 17; table 1; sequences ID NO. 24-26 *;
 [AP]WO2012173422  (HANMI SCIENCE CO LTD [KR], et al) [AP] 1-14 * page 25; table 1; sequences ID NO. 24-26 * * page 18, paragraph 220 * * page 1, paragraphs 1, 4 * * page 16, paragraph 204 * * page 17, paragraph 208 *
ExaminationWO2011075393
by applicantWO9632478
 WO9734631
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.